These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 11340292)
1. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia. Kitagawa Y; Namiki M Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935 [TBL] [Abstract][Full Text] [Related]
2. Cumulative probability of prostate cancer detection in biopsy according to free/total PSA ratio in men with total PSA levels of 2.1-10.0 ng/ml at population screening. Kitagawa Y; Ueno S; Izumi K; Kadono Y; Konaka H; Mizokami A; Namiki M J Cancer Res Clin Oncol; 2014 Jan; 140(1):53-9. PubMed ID: 24165867 [TBL] [Abstract][Full Text] [Related]
3. Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer. Lilja H Eur Urol; 2001 Apr; 39 Suppl 4():47-8. PubMed ID: 11340291 [No Abstract] [Full Text] [Related]
4. Precursor isoform of prostate-specific antigen and human kallikrein 2: two new promising biomarkers for the unsolved challenge of early prostate cancer detection. Ficarra V; Novara G; Galfano A Eur Urol; 2009 Mar; 55(3):556-9. PubMed ID: 19111385 [No Abstract] [Full Text] [Related]
5. Diagnosis, characterization and potential clinical relevance of prostate cancer detected at low PSA ranges. Schröder FH Eur Urol; 2001 Apr; 39 Suppl 4():49-53. PubMed ID: 11340292 [No Abstract] [Full Text] [Related]
6. PSA and other tissue kallikreins for prostate cancer detection. Stephan C; Jung K; Lein M; Diamandis EP Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069 [TBL] [Abstract][Full Text] [Related]
7. [Biological markers of prostate cancer]. Seitz C; Djavan B Ann Urol (Paris); 2006 Dec; 40(6):329-35. PubMed ID: 17214230 [TBL] [Abstract][Full Text] [Related]